(−)-Oleocanthal as a Dual c-MET-COX2 Inhibitor for the Control of Lung Cancer

Lung cancer (LC) represents the topmost mortality-causing cancer in the U.S. LC patients have overall poor survival rate with limited available treatment options. Dysregulation of the mesenchymal epithelial transition factor (c-MET) and cyclooxygenase 2 (COX2) initiates aggressive LC profile in a su...

Descripción completa

Detalles Bibliográficos
Autores principales: Siddique, Abu Bakar, Kilgore, Phillip C.S.R., Tajmim, Afsana, Singh, Sitanshu S., Meyer, Sharon A., Jois, Seetharama D., Cvek, Urska, Trutschl, Marjan, Sayed, Khalid A. El
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7353354/
https://www.ncbi.nlm.nih.gov/pubmed/32545325
http://dx.doi.org/10.3390/nu12061749

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7353354/
https://www.ncbi.nlm.nih.gov/pubmed/32545325
http://dx.doi.org/10.3390/nu12061749

Ejemplares similares